News Daily News No Clear Risk of Dementia After TIA: Framingham Heart Study It may be that patients have better control of cerebrovascular risk factors after the event, protecting against future impairment. L.A. McKeown July 10, 2025
Presentation ACC 2025 Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension Presenter: Luke Laffin March 29, 2025
Presentation ACC 2025 Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial Presenter: Darren K. McGuire March 29, 2025
Presentation ACC 2025 Four-Factor Prothrombin Complex Concentrate is Superior to Frozen Plasma in Bleeding Adult Cardiac Surgery Patients with Coagulopathy—Results from a Phase 3, Randomized, Active-Control Study Presenter: Keyvan Karkouti March 29, 2025
Presentation Controversies and Advances 2025 Cuffless blood pressure devices: Are they ready for prime time? Presenter: Jennifer L. Cluett January 30, 2025
Presentation Controversies and Advances 2025 Management of Hyperaldosteronism: Adrenalectomy Has the Best Outcomes! Presenter: Yufei Chen January 30, 2025
News Daily News Baxdrostat Shows Promise in Uncontrolled or Resistant Hypertension By L.A. McKeown July 14, 2025
News Daily News No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits By Michael O'Riordan July 14, 2025
News Daily News CMS Issues Proposed Coverage Decision for Renal Denervation By Todd Neale July 11, 2025
News Daily News Novel Calcium Score Accounting for Density and Location Ups MACE Prediction By Yael L. Maxwell July 11, 2025
News Daily News No Clear Risk of Dementia After TIA: Framingham Heart Study By L.A. McKeown July 10, 2025